Stock 000912061 BECTON, DICKINSON AND COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

News Becton, Dickinson and Company Berne S.E.

Equities

000912061

US0758871091

Delayed Berne S.E.
Other stock markets
 17:00:02 05/02/2024 GMT 		5-day change 1st Jan Change
206 CHF -.--% Intraday chart for Becton, Dickinson and Company -18.36% -13.47%
07-02 Evercore ISI Adjusts Price Target on Becton, Dickinson to $285 From $290, Maintains Outperform Rating MT
06-26 BD (Becton, Dickinson and Company) Announces the Commercial Launch of a New Single-Cell Research Tool CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Evercore ISI Adjusts Price Target on Becton, Dickinson to $285 From $290, Maintains Outperform Rating
MT
New BD Research Tool Helps Scientists Study Cells that are Often Key Culprits in the Development of Cancer and Infectious Diseases
PR
BD (Becton, Dickinson and Company) Announces the Commercial Launch of a New Single-Cell Research Tool
CI
Tandem Diabetes Care, Inc. Appoints Jean-Claude Kyrillos as Executive Vice President and Chief Operating Officer, Effective June 21, 2024
CI
BD Announces Dates for Third Quarter and Fourth Quarter Fiscal 2024 Earnings Webcasts
PR
Evercore ISI Raises Becton, Dickinson and Company's Price Target to $290 From $282
MT
Becton Dickinson and : BD Issues Annual Product Security Report, Highlighting Transparency and Collaboration
PU
Ex-dividend day
FA
Sector Update: Health Care Stocks Steady Premarket Monday
MT
Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion in Cash
DJ
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash
MT
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln
RE
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion
MT
Becton, Dickinson and Company entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion.
CI
DBS Bank Adjusts Price Target on Becton, Dickinson to $285 From $300
MT
Transcript : Becton, Dickinson and Company Presents at Bank of America Health Care Conference 2024, May-14-2024 08:00 AM
Becton Dickinson and : Rima Alameddine Named President of BD Peripheral Intervention
PU
Exclusive-Biden to put tariffs on China medical supplies - sources
RE
Becton Dickinson and : BD, City of Hope to Offer Pharmacy Residency Program for Medication-Use Safety and Policy
PU
Barclays Adjusts Price Target on Becton, Dickinson to $312 From $305, Keeps Overweight Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BDX Stock
  4. 000912061 Stock
  5. News Becton, Dickinson and Company